State Street’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.4M | Buy |
1,781,501
+63,777
| +4% | +$836K | ﹤0.01% | 2106 |
|
|
2025
Q1 | $37.8M | Buy |
1,717,724
+2,179
| +0.1% | +$47.9K | ﹤0.01% | 1792 |
|
|
2024
Q4 | $45.8M | Buy |
1,715,545
+30,430
| +2% | +$812K | ﹤0.01% | 1757 |
|
|
2024
Q3 | $45M | Buy |
1,685,115
+20,020
| +1% | +$534K | ﹤0.01% | 1758 |
|
|
2024
Q2 | $30M | Buy |
1,665,095
+453,619
| +37% | +$8.17M | ﹤0.01% | 1932 |
|
|
2024
Q1 | $22.1M | Buy |
1,211,476
+318,767
| +36% | +$5.81M | ﹤0.01% | 2151 |
|
|
2023
Q4 | $9.77M | Buy |
892,709
+104,449
| +13% | +$1.14M | ﹤0.01% | 2608 |
|
|
2023
Q3 | $4.52M | Buy |
788,260
+39,888
| +5% | +$229K | ﹤0.01% | 2968 |
|
|
2023
Q2 | $5.8M | Buy |
748,372
+89,749
| +14% | +$696K | ﹤0.01% | 2928 |
|
|
2023
Q1 | $4.39M | Buy |
658,623
+59,103
| +10% | +$394K | ﹤0.01% | 3043 |
|
|
2022
Q4 | $5.36M | Buy |
599,520
+37,194
| +7% | +$333K | ﹤0.01% | 3012 |
|
|
2022
Q3 | $5.53M | Buy |
562,326
+37,602
| +7% | +$370K | ﹤0.01% | 3008 |
|
|
2022
Q2 | $4.18M | Sell |
524,724
-39,486
| -7% | -$314K | ﹤0.01% | 3186 |
|
|
2022
Q1 | $5.47M | Buy |
564,210
+35,572
| +7% | +$345K | ﹤0.01% | 3135 |
|
|
2021
Q4 | $8.08M | Buy |
528,638
+329,542
| +166% | +$5.04M | ﹤0.01% | 3023 |
|
|
2021
Q3 | $3.31M | Buy |
199,096
+21,594
| +12% | +$358K | ﹤0.01% | 3445 |
|
|
2021
Q2 | $3.79M | Buy |
+177,502
| New | +$3.79M | ﹤0.01% | 3368 |
|